What Medicare Covers for Substance Use Care
SaveAddiction treatment is a covered part of Medicare, spread across hospital, outpatient, and drug benefits, with a dedicated pathway for opioid treatment programs. But Medicare's cost-sharing and covered settings are defined by its own rules and differ between Original Medicare and Advantage plans. This page explains what the care consists of, what the evidence supports, and how to confirm your own coverage.
Last updated: July 2026History
Does Medicare cover addiction treatment?
Generally, yes. Medicare covers substance-use disorder care across its parts — hospital-based inpatient treatment, outpatient counseling and services, prescription medications, and care delivered through opioid treatment programs. What you actually pay, and which settings are covered, are defined by Medicare's own benefit rules and differ depending on whether you have Original Medicare or a Medicare Advantage plan.
Because those specifics are set by Medicare and change over time, the reliable move is to confirm the line-item details through official Medicare information — the Medicare.gov coverage pages and the official Medicare handbook — rather than a treatment center's marketing. The benefit exists; the exact cost-sharing and covered settings are program details to verify against Medicare's own rules, not something a rehab's website should be your source for. This page explains what the care consists of and how to check yours.
How parity fits — and how Medicare differs
It helps to know where the federal parity law does and does not reach. The Mental Health Parity and Addiction Equity Act generally bars a health plan that covers substance-use benefits from imposing more restrictive financial requirements or treatment limits on that care than on comparable medical and surgical care 1Ref 1Centers for Medicare & Medicaid Services (2024).Mental Health Parity and Addiction Equity Act (MHPAEA).That MHPAEA (2008) generally requires plans covering substance-use benefits not to impose more restrictive financial requirements or treatment limits than for medical/surgical benefits, but does not itself mandate that a plan cover a given service.. That framework shapes much of private and Medicaid managed-care coverage.
Medicare, however, is governed by its own benefit structure rather than by that private-plan parity framework, which is why the way to answer a Medicare coverage question is to read Medicare's own rules and, if you have a Medicare Advantage plan, that plan's specific terms. The general shape of how does insurance pay for rehab still applies — deductibles, covered settings, prior authorization — but the authoritative source for Medicare is Medicare itself.
What the covered care actually consists of
Addiction treatment is not one service; it is a continuum, and knowing its shape helps you ask about coverage precisely. The ASAM Criteria describe a standardized continuum of levels of care — from outpatient through intensive outpatient and residential up to medically managed intensive inpatient — and support placing a person by assessed severity rather than by a fixed program 2Ref 2American Society of Addiction Medicine (2024).The ASAM Criteria.That the ASAM Criteria define a standardized continuum of levels of care from outpatient through medically managed intensive inpatient, and support placing a person by assessed severity rather than a fixed program.. Care can include medical stabilization, individual and group therapy, and medication.
When you contact Medicare or a plan, ask about the levels you actually need rather than 'rehab' in the abstract. Outpatient counseling, a partial-hospitalization program, residential care, and medication each sit at different points on that continuum and may be handled by different parts of Medicare. Framing the question around the specific level of care makes the coverage answer far clearer than a general query does.
Medication, and why methadone's setting matters
Medication is central to modern addiction treatment, so it is worth understanding how it is delivered. Medication for opioid use disorder is an evidence-based standard of care: at therapeutic doses, methadone and buprenorphine reduce cravings and withdrawal without producing a high, which is why treating opioid use disorder this way is not 'substituting one addiction for another' 3Ref 3National Institute on Drug Abuse (2024).Medications for Opioid Use Disorder.That medications for opioid use disorder are an evidence-based standard of care, and that treating opioid use disorder with methadone or buprenorphine is not 'substituting one addiction for another' because at therapeutic doses they reduce cravings and withdrawal without producing a high.. This is the core of medication-assisted treatment.
How a medication is dispensed shapes how it is billed. Methadone for addiction is provided through federally regulated opioid treatment programs under 42 CFR Part 8, and a 2024 final rule expanded access, including more take-home doses and telehealth initiation, and removed the prior requirement of a year of addiction before admission 4Ref 4Substance Abuse and Mental Health Services Administration (2024).42 CFR Part 8 Final Rule.That opioid treatment programs dispensing methadone are federally regulated under 42 CFR Part 8, and that the 2024 final rule expanded access, including more take-home doses, telehealth initiation, and removal of the prior one-year-of-addiction admission requirement.. Because methadone comes through these programs rather than a retail pharmacy, it is worth looking up the opioid treatment program Medicare benefit specifically when you check coverage. Buprenorphine, by contrast, is usually prescribed in a clinic and filled at a pharmacy, so it follows the drug-benefit path. No dose or regimen is described here — that belongs to a prescriber and the pharmacy label.
What the evidence says is worth prioritizing
Not every covered service is equally effective, and that matters when you decide where to spend covered visits. A large comparison of treatment pathways in adults with opioid use disorder found that only buprenorphine or methadone was associated with reduced overdose and serious opioid-related acute care, while inpatient or residential treatment and intensive behavioral interventions alone were not 5Ref 5Wakeman SE, Larochelle MR, Ameli O, et al. (2020).Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.That among treatment pathways for opioid use disorder, only buprenorphine or methadone was associated with reduced overdose and serious opioid-related acute care, while inpatient/residential treatment and intensive behavioral interventions alone were not.. In plain terms: a residential stay without medication did not, on its own, reduce overdose in that analysis.
The practical lesson for anyone using Medicare coverage is to prioritize care that includes medication where it is indicated, rather than assuming an expensive residential program is automatically the strongest option. Weighing medication-assisted treatment against abstinence-only approaches is a clinical conversation worth having with a prescriber, and coverage for the medication is often the more consequential question than coverage for the setting.
This reframes how to spend a coverage benefit that is not unlimited. A course of medication with ongoing outpatient support may do more for someone than a single high-cost residential stay, and it is usually far more sustainable over the months that recovery actually takes. When you ask about coverage, asking whether the medication and the follow-up care are covered — not just the initial program — is the question most aligned with what the evidence supports.
How to confirm your own Medicare coverage
The dependable way to know what your Medicare will pay is to check Medicare's own information and your specific plan. Use the official Medicare.gov coverage pages and, if you have a Medicare Advantage plan, that plan's documents, and ask concrete questions: which levels of substance-use care are covered, whether the medication you need is covered and how, what prior authorization applies, and which providers are in network. Ask the treatment program's billing office the same, and get answers in writing where you can.
To find a provider or program in the first place, start from a neutral government tool rather than a search ad. SAMHSA maintains official locators, including an opioid-treatment-program locator and a buprenorphine-practitioner locator, that point to real, regulated providers 6Ref 6Substance Abuse and Mental Health Services Administration (2024).Treatment Locators: Mental Health, Drug, Alcohol Issues.That SAMHSA maintains official locators, including an opioid-treatment-program locator and a buprenorphine-practitioner locator, pointing to real, regulated providers rather than commercial referral lines.. Confirm any specific provider against Medicare and your plan before committing. If you also have Medicaid, note that Medicaid and rehab coverage follows its own state-by-state rules, so read each program's coverage on its own terms rather than assuming they match.
Common questions
Related
Substance use & recovery
How Medicaid Covers Addiction TreatmentSubstance use & recovery
How Insurance Covers Addiction MedicationsSubstance use & recovery
What Your Employee Assistance Program Offers for Addiction
Deciding about this?
A short, sourced overview to weigh with your clinician:
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
If things feel heavy, a person is available anytime — call or text 988.
If care is urgent, do not wait on a coverage answer
- —Severe alcohol or benzodiazepine withdrawal — shaking, sweating, confusion, or a racing heart — while a Medicare coverage question is still unresolved
- —A program pressuring you to admit immediately, or promising to waive your Medicare costs, before you can verify its license
- —Being told to stop a working medication for opioid use disorder because of a coverage or plan change, without a clinician's plan
If severe withdrawal appears — confusion, hallucinations, a seizure, or a dangerously fast heartbeat — call 911 or go to the nearest emergency room. If an opioid overdose is suspected, call 911 and give naloxone if available. For a mental-health crisis, call or text 988.
This article is educational and explains Medicare and substance-use care in general terms; it is not insurance, legal, or medical advice and does not describe any dose or regimen. Coverage specifics are defined by Medicare's own rules and should be confirmed through official Medicare information or your plan.
Did this answer your question?
References
- 1.Centers for Medicare & Medicaid Services (2024). Mental Health Parity and Addiction Equity Act (MHPAEA). Centers for Medicare & Medicaid Services (CMS). link ✓That MHPAEA (2008) generally requires plans covering substance-use benefits not to impose more restrictive financial requirements or treatment limits than for medical/surgical benefits, but does not itself mandate that a plan cover a given service.
- 2.American Society of Addiction Medicine (2024). The ASAM Criteria. American Society of Addiction Medicine (ASAM). link ✓That the ASAM Criteria define a standardized continuum of levels of care from outpatient through medically managed intensive inpatient, and support placing a person by assessed severity rather than a fixed program.
- 3.National Institute on Drug Abuse (2024). Medications for Opioid Use Disorder. National Institute on Drug Abuse (NIDA), NIH. link ✓That medications for opioid use disorder are an evidence-based standard of care, and that treating opioid use disorder with methadone or buprenorphine is not 'substituting one addiction for another' because at therapeutic doses they reduce cravings and withdrawal without producing a high.
- 4.Substance Abuse and Mental Health Services Administration (2024). 42 CFR Part 8 Final Rule. SAMHSA. link ✓That opioid treatment programs dispensing methadone are federally regulated under 42 CFR Part 8, and that the 2024 final rule expanded access, including more take-home doses, telehealth initiation, and removal of the prior one-year-of-addiction admission requirement.
- 5.Wakeman SE, Larochelle MR, Ameli O, et al. (2020). Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder. JAMA Network Open. doi:10.1001/jamanetworkopen.2019.20622 ✓That among treatment pathways for opioid use disorder, only buprenorphine or methadone was associated with reduced overdose and serious opioid-related acute care, while inpatient/residential treatment and intensive behavioral interventions alone were not.
- 6.Substance Abuse and Mental Health Services Administration (2024). Treatment Locators: Mental Health, Drug, Alcohol Issues. SAMHSA. link ✓That SAMHSA maintains official locators, including an opioid-treatment-program locator and a buprenorphine-practitioner locator, pointing to real, regulated providers rather than commercial referral lines.
6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy